Becton Dickinson Net Income 2010-2024 | BDX

Becton Dickinson annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Becton Dickinson net income for the quarter ending March 31, 2024 was $0.537B, a 22.6% increase year-over-year.
  • Becton Dickinson net income for the twelve months ending March 31, 2024 was $1.318B, a 13.69% decline year-over-year.
  • Becton Dickinson annual net income for 2023 was $1.424B, a 15.69% decline from 2022.
  • Becton Dickinson annual net income for 2022 was $1.689B, a 15.63% decline from 2021.
  • Becton Dickinson annual net income for 2021 was $2.002B, a 161.02% increase from 2020.
Becton Dickinson Annual Net Income
(Millions of US $)
2023 $1,424
2022 $1,689
2021 $2,002
2020 $767
2019 $1,082
2018 $159
2017 $1,030
2016 $976
2015 $695
2014 $1,185
2013 $1,293
2012 $1,170
2011 $1,271
2010 $1,318
2009 $1,232
Becton Dickinson Quarterly Net Income
(Millions of US $)
2024-03-31 $537
2023-12-31 $281
2023-09-30 $108
2023-06-30 $392
2023-03-31 $438
2022-12-31 $486
2022-09-30 $265
2022-06-30 $338
2022-03-31 $431
2021-12-31 $655
2021-09-30 $242
2021-06-30 $502
2021-03-31 $277
2020-12-31 $981
2020-09-30 $105
2020-06-30 $277
2020-03-31 $145
2019-12-31 $240
2019-09-30 $125
2019-06-30 $413
2019-03-31 $-18
2018-12-31 $562
2018-09-30 $-173
2018-06-30 $556
2018-03-31 $-50
2017-12-31 $-174
2017-09-30 $289
2017-06-30 $-165
2017-03-31 $344
2016-12-31 $562
2016-09-30 $19
2016-06-30 $390
2016-03-31 $338
2015-12-31 $229
2015-09-30 $181
2015-06-30 $62
2015-03-31 $216
2014-12-31 $236
2014-09-30 $301
2014-06-30 $326
2014-03-31 $287
2013-12-31 $271
2013-09-30 $90
2013-06-30 $302
2013-03-31 $276
2012-12-31 $625
2012-09-30 $289
2012-06-30 $327
2012-03-31 $291
2011-12-31 $263
2011-09-30 $300
2011-06-30 $343
2011-03-31 $312
2010-12-31 $316
2010-09-30 $397
2010-06-30 $307
2010-03-31 $298
2009-12-31 $316
2009-09-30 $317
2009-06-30 $341
2009-03-31 $261
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.549B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00